Literature DB >> 15686860

Further validation of a cognitive-behavioral model of generalized anxiety disorder: diagnostic and symptom specificity.

Michel J Dugas1, André Marchand, Robert Ladouceur.   

Abstract

The goal of this study was to investigate the diagnostic and symptom specificity of a model of GAD that has four main features: intolerance of uncertainty, positive beliefs about worry, poor problem orientation, and cognitive avoidance. The authors compared 17 patients with non-comorbid generalized anxiety disorder (GAD) to 28 patients with non-comorbid panic disorder with agoraphobia (PDA) and found that only intolerance of uncertainty showed evidence of diagnostic specificity, i.e., intolerance of uncertainty scores were higher in the GAD group relative to the PDA group. In terms of symptom specificity, when both groups were combined, all model variables were significantly related to worry but unrelated to fear of bodily sensations, agoraphobic cognitions, and behavioral avoidance. Taken together, these findings provide further support for the link between intolerance of uncertainty and GAD and underscore the importance of pursuing the issue of specificity from both a diagnostic and symptom perspective.

Entities:  

Mesh:

Year:  2005        PMID: 15686860     DOI: 10.1016/j.janxdis.2004.02.002

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  27 in total

1.  Latent dimensions of social anxiety disorder: A re-evaluation of the Social Phobia Inventory (SPIN).

Authors:  Laura Campbell-Sills; Emmanuel Espejo; Catherine R Ayers; Peter Roy-Byrne; Murray B Stein
Journal:  J Anxiety Disord       Date:  2015-09-18

Review 2.  Toward an account of clinical anxiety predicated on basic, neurally mapped mechanisms of Pavlovian fear-learning: the case for conditioned overgeneralization.

Authors:  Shmuel Lissek
Journal:  Depress Anxiety       Date:  2012-03-23       Impact factor: 6.505

Review 3.  Neural substrates of childhood anxiety disorders: a review of neuroimaging findings.

Authors:  Jennifer Urbano Blackford; Daniel S Pine
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-06-04

4.  Generalized anxiety disorder is associated with overgeneralization of classically conditioned fear.

Authors:  Shmuel Lissek; Antonia N Kaczkurkin; Stephanie Rabin; Marilla Geraci; Daniel S Pine; Christian Grillon
Journal:  Biol Psychiatry       Date:  2013-08-31       Impact factor: 13.382

5.  Is a gin and tonic more like gin or tonic? A comparison of comorbid and non-comorbid anxiety disorder diagnostic pairs.

Authors:  Peter J Norton; Tannah E Chase
Journal:  Psychiatry Res       Date:  2014-11-15       Impact factor: 3.222

Review 6.  Current considerations in the treatment of generalized anxiety disorder.

Authors:  Martin A Katzman
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  Can the components of a cognitive model predict the severity of generalized anxiety disorder?

Authors:  Michel J Dugas; Pierre Savard; Adrienne Gaudet; Julie Turcotte; Nina Laugesen; Melisa Robichaud; Kylie Francis; Naomi Koerner
Journal:  Behav Ther       Date:  2007-02-08

8.  The intolerance of uncertainty scale for children: a psychometric evaluation.

Authors:  Jonathan S Comer; Amy K Roy; Jami M Furr; Kristin Gotimer; Rinad S Beidas; Michel J Dugas; Philip C Kendall
Journal:  Psychol Assess       Date:  2009-09

9.  Examination of the Intolerance of Uncertainty Construct in Youth With Generalized Anxiety Disorder.

Authors:  Jennifer Cowie; Michelle A Clementi; Candice A Alfano
Journal:  J Clin Child Adolesc Psychol       Date:  2016-09-21

Review 10.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.